Literature DB >> 24275455

The ubiquitin ligase RNF126 regulates the retrograde sorting of the cation-independent mannose 6-phosphate receptor.

Christopher J Smith1, C Jane McGlade2.   

Abstract

The ubiquitin proteasome system is central to the regulation of a number of intracellular sorting pathways in mammalian cells including quality control at the endoplasmic reticulum and the internalization and endosomal sorting of cell surface receptors. Here we describe that RNF126, an E3 ubiquitin ligase, is involved in the sorting of the cation-independent mannose 6-phosphate receptor (CI-MPR). In cells transiently depleted of RNF126, the CI-MPR is dispersed into Rab4 positive endosomes and the efficiency of retrograde sorting is delayed. Furthermore, the stable knockdown of RNF126 leads to the lysosomal degradation of CI-MPR and missorting of cathepsin D. RNF126 specifically regulates the sorting of the CI-MPR as other cargo that follow the retrograde sorting route including the cholera toxin, furin and TGN38 are unaffected in the absence of RNF126. Lastly we show that the RING finger domain of RNF126 is required to rescue the decrease in CI-MPR levels, suggesting that the ubiquitin ligase activity of RNF126 is required for CI-MPR sorting. Together, our data indicate that the ubiquitin ligase RNF126 has a role in the retrograde sorting of the CI-MPR.
© 2013 Published by Elsevier Inc.

Entities:  

Keywords:  CI-MPR; E3 ubiquitin ligase; EGFR; GGA; Golgi-localized ϒ ear containing, ARF binding protein; HEK; PACS; RNF126; Retrograde sorting; TGN; TfR; cation-independent mannose 6-phosphate receptor; epidermal growth factor receptor; human embryonic kidney; phosphofurin acidic cluster protein-1; siRNA; small interfering RNA; trans-Golgi network; transferrin receptor

Mesh:

Substances:

Year:  2013        PMID: 24275455     DOI: 10.1016/j.yexcr.2013.11.013

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  Ubiquitylation of Ku80 by RNF126 Promotes Completion of Nonhomologous End Joining-Mediated DNA Repair.

Authors:  Noriko Ishida; Tadashi Nakagawa; Shun-Ichiro Iemura; Akira Yasui; Hiroki Shima; Yasutake Katoh; Yuko Nagasawa; Toru Natsume; Kazuhiko Igarashi; Keiko Nakayama
Journal:  Mol Cell Biol       Date:  2017-02-01       Impact factor: 4.272

2.  RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells.

Authors:  Xiaosong Yang; You Pan; Zhaojun Qiu; Zhanwen Du; Yao Zhang; Pengyan Fa; Shashank Gorityala; Shanhuai Ma; Shunqiang Li; Ceshi Chen; Hongbing Wang; Yan Xu; Chunhong Yan; Keri Ruth; Zhefu Ma; Junran Zhang
Journal:  Clin Cancer Res       Date:  2018-01-11       Impact factor: 12.531

3.  In-Frame Indel Mutations in the Genome of the Blind Mexican Cavefish, Astyanax mexicanus.

Authors:  Daniel Berning; Hannah Adams; Heidi Luc; Joshua B Gross
Journal:  Genome Biol Evol       Date:  2019-09-01       Impact factor: 3.416

4.  High Expression of RING Finger Protein 126 Predicts Unfavorable Prognosis of Epithelial Ovarian Cancer.

Authors:  Chuanjiang Wang; Aiping Wen; Jing Qiao; Yujuan Liu; Yuanyuan Guo; Wenxia Wang
Journal:  Med Sci Monit       Date:  2020-04-07

5.  Structural and functional insights into the E3 ligase, RNF126.

Authors:  Ewelina M Krysztofinska; Santiago Martínez-Lumbreras; Arjun Thapaliya; Nicola J Evans; Stephen High; Rivka L Isaacson
Journal:  Sci Rep       Date:  2016-05-19       Impact factor: 4.379

6.  The ERK signaling target RNF126 regulates anoikis resistance in cancer cells by changing the mitochondrial metabolic flux.

Authors:  Seiko Yoshino; Toshiro Hara; Hiroki J Nakaoka; Akane Kanamori; Yoshinori Murakami; Motoharu Seiki; Takeharu Sakamoto
Journal:  Cell Discov       Date:  2016-07-26       Impact factor: 10.849

7.  E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia.

Authors:  Monica Benini; Silvia Fortuni; Ivano Condò; Giulia Alfedi; Florence Malisan; Nicola Toschi; Dario Serio; Damiano Sergio Massaro; Gaetano Arcuri; Roberto Testi; Alessandra Rufini
Journal:  Cell Rep       Date:  2017-02-21       Impact factor: 9.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.